e-learning
resources
Vienna 2003
Sunday 28.09.2003
Models and markers of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impaired relaxation of pulmonary arteries to endothelium-dependent vasodilators in smokers with mild COPD
O. Fira-Mladinescu, D. Muntean, C. Fira-Mladinescu (Timisoara, Romania)
Source:
Annual Congress 2003 - Models and markers of COPD
Session:
Models and markers of COPD
Session type:
Thematic Poster Session
Number:
608
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Fira-Mladinescu, D. Muntean, C. Fira-Mladinescu (Timisoara, Romania). Impaired relaxation of pulmonary arteries to endothelium-dependent vasodilators in smokers with mild COPD. Eur Respir J 2003; 22: Suppl. 45, 608
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
NO-generating endothelium function and endothelium-dependent vasodilatation of brachial artery in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004
Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2009; 33: 1354-1360
Year: 2009
Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002
Experience with pulmonary selective vasodilator treatment in COPD with severe pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Flow-mediated dilation of the brachial artery and endothelial dysfunction in different COPD phenotypes
Source: International Congress 2015 – Different data in COPD
Year: 2015
Oral sildenafil is a potent pulmonary vasodilator and improves gas exchange in patients with COPD with pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006
Endothelium-independent dilatation of the brachial artery in patients with the bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 403s
Year: 2006
Inhaled iloprost improves hemodynamics at exercise in primary and secondary precapillary pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003
The status of venous vasodilator, vasoconstrictors in high-altitude pulmonary edema susceptible subjects under hypoxic exposure
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Endothelium-dependent relaxation and hypoxic pulmonary vascular response in isolated pulmonary arteries of endothelial nitric oxide synthase-deficient mice
Source: Eur Respir J 2002; 20: Suppl. 38, 4s
Year: 2002
Endothelial dysfunction in patients with bronchial asthma with and without arterial hypertension
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Smoking induced pulmonary vascular remodelling in patients with mild COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Predictors of a precapillary component in patients with postcapillary pulmonary hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept